应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ONCO Onconetix Inc.
已收盘 02-10 16:00:00 EST
1.51
+0.32
+26.89%
盘后
1.42
-0.09
-5.70%
19:56 EST
最高
1.52
最低
1.23
成交量
8.48万
今开
1.23
昨收
1.19
日振幅
24.37%
总市值
235.66万
流通市值
187.72万
总股本
156.07万
成交额
12.00万
换手率
6.82%
流通股本
124.32万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Onconetix, Inc.盘中异动 早盘快速拉升5.98%报1.24美元
市场透视 · 02-09 22:32
Onconetix, Inc.盘中异动 早盘快速拉升5.98%报1.24美元
Onconetix, Inc.盘中异动 股价大跌5.28%
市场透视 · 02-02
Onconetix, Inc.盘中异动 股价大跌5.28%
Onconetix, Inc.盘中异动 下午盘大幅上涨5.41%
市场透视 · 01-15
Onconetix, Inc.盘中异动 下午盘大幅上涨5.41%
Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案
美股速递 · 2025-12-22
Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案
Onconetix Inc. - 提交22.1百万普通股转售的招股说明书 - SEC备案
投资观察 · 2025-11-20
Onconetix Inc. - 提交22.1百万普通股转售的招股说明书 - SEC备案
Onconetix, Inc.盘中异动 股价大跌5.80%
市场透视 · 2025-10-31
Onconetix, Inc.盘中异动 股价大跌5.80%
Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案
美股速递 · 2025-10-16
Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案
Onconetix, Inc.盘中异动 快速跳水5.61%报3.03美元
市场透视 · 2025-09-30
Onconetix, Inc.盘中异动 快速跳水5.61%报3.03美元
Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,终止与Ocuvex Inc.的并购协议并与Veru Inc.达成880万美元债务和解
美股速递 · 2025-09-26
Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,终止与Ocuvex Inc.的并购协议并与Veru Inc.达成880万美元债务和解
Onconetix Inc与Ocuvex决定各自独立发展最符合利益相关者利益
美股速递 · 2025-09-26
Onconetix Inc与Ocuvex决定各自独立发展最符合利益相关者利益
Onconetix Inc.宣布子公司Proteomedix向Immunovia授权制造知识产权,助力后者独立生产胰腺癌检测试剂
美股速递 · 2025-09-22
Onconetix Inc.宣布子公司Proteomedix向Immunovia授权制造知识产权,助力后者独立生产胰腺癌检测试剂
Onconetix, Inc.盘中异动 急速下跌10.39%报0.206美元
市场透视 · 2025-03-10
Onconetix, Inc.盘中异动 急速下跌10.39%报0.206美元
Onconetix, Inc.盘中异动 早盘股价大涨8.04%
市场透视 · 2025-03-03
Onconetix, Inc.盘中异动 早盘股价大涨8.04%
Onconetix, Inc.盘中异动 早盘股价大跌5.57%报0.290美元
市场透视 · 2025-02-28
Onconetix, Inc.盘中异动 早盘股价大跌5.57%报0.290美元
Onconetix, Inc.盘中异动 早盘股价大跌5.60%报0.472美元
市场透视 · 2025-02-19
Onconetix, Inc.盘中异动 早盘股价大跌5.60%报0.472美元
Onconetix, Inc.盘中异动 急速下挫5.26%
市场透视 · 2025-02-10
Onconetix, Inc.盘中异动 急速下挫5.26%
Onconetix, Inc.盘中异动 早盘快速跳水6.46%报0.612美元
市场透视 · 2025-02-07
Onconetix, Inc.盘中异动 早盘快速跳水6.46%报0.612美元
Onconetix, Inc.盘中异动 快速拉升5.09%
市场透视 · 2025-02-05
Onconetix, Inc.盘中异动 快速拉升5.09%
Onconetix, Inc.盘中异动 早盘快速跳水5.40%报0.515美元
市场透视 · 2025-02-03
Onconetix, Inc.盘中异动 早盘快速跳水5.40%报0.515美元
加载更多
公司概况
公司名称:
Onconetix Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司,专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生(BPH)(一种前列腺疾病)的口服治疗药物EntadFi,以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原(PSA)评估不确定的男性的先进专有诊断系统Proclarix。
发行价格:
--
{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":1.51,"timestamp":1770757200000,"preClose":1.19,"halted":0,"volume":84796,"hourTrading":{"tag":"盘后","latestPrice":1.424,"preClose":1.51,"latestTime":"19:56 EST","volume":1779,"amount":2555.0175,"timestamp":1770771400475,"change":-0.086,"changeRate":-0.056954,"amplitude":0.072781},"delay":0,"changeRate":0.26890756302521013,"floatShares":1243200,"shares":1560668,"eps":-32.579,"marketStatus":"已收盘","change":0.32,"latestTime":"02-10 16:00:00 EST","open":1.23,"high":1.52,"low":1.23,"amount":119962.11378279999,"amplitude":0.243697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-32.579,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":5,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":1.19,"preHourTrading":{"tag":"盘前","latestPrice":1.21,"preClose":1.19,"latestTime":"08:22 EST","volume":53,"amount":64.13,"timestamp":1770729745426,"change":0.02,"changeRate":0.016807,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.424,"preClose":1.51,"latestTime":"19:56 EST","volume":1779,"amount":2555.0175,"timestamp":1770771400475,"change":-0.086,"changeRate":-0.056954,"amplitude":0.072781},"volumeRatio":1.110009},"requestUrl":"/m/hq/s/ONCO","defaultTab":"news","newsList":[{"id":"2610651856","title":"Onconetix, Inc.盘中异动 早盘快速拉升5.98%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651856?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:32","pubTimestamp":1770647558,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时32分,Onconetix, Inc.股票出现波动,股价大幅拉升5.98%。截至发稿,该股报1.24美元/股,成交量614股,换手率0.04%,振幅0.81%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Onconetix, Inc.公司简介:Onconetix Inc 是一家处于商业化阶段的生物技术公司,专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2608815965","title":"Onconetix, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608815965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608815965?lang=zh_cn&edition=full","pubTime":"2026-02-02 23:46","pubTimestamp":1770047191,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日23时46分,Onconetix, Inc.股票出现异动,股价大幅跳水5.28%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Onconetix, Inc.公司简介:Onconetix Inc 是一家处于商业化阶段的生物技术公司,专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202234631a473eb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202234631a473eb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2603057646","title":"Onconetix, Inc.盘中异动 下午盘大幅上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603057646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603057646?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:30","pubTimestamp":1768415408,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日02时30分,Onconetix, Inc.股票出现波动,股价大幅上涨5.41%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Alpha Tau Medical Ltd C/Wts 、Bioatla, Inc.、Scinai Immunotherapeutics Ltd涨幅较大,Briacell Therapeutics Corp.、Clearmind Medicine Inc.、Nrx Pharmaceuticals, Inc.较为活跃,换手率分别为248.64%、80.08%、70.18%,振幅较大的相关个股有Alpha Tau Medical Ltd C/Wts 、Briacell Therapeutics Corp C/Wts 、60 Degrees Pharmaceuticals, Inc.,振幅分别为56.54%、46.51%、39.81%。Onconetix, Inc.公司简介:Onconetix Inc 是一家处于商业化阶段的生物技术公司,专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011502300897a1d5c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011502300897a1d5c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1175357476","title":"Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1175357476","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175357476?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:09","pubTimestamp":1766401780,"startTime":"0","endTime":"0","summary":"Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1172459660","title":"Onconetix Inc. - 提交22.1百万普通股转售的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1172459660","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172459660?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:36","pubTimestamp":1763570197,"startTime":"0","endTime":"0","summary":"11月5日 - Onconetix Inc. ::*ONCONETIX INC - 提交22.1百万普通股转售的招股说明书,卖方股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2580417790","title":"Onconetix, Inc.盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417790?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:50","pubTimestamp":1761918624,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时50分,Onconetix, Inc.股票出现异动,股价大幅下挫5.80%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Ardelyx, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Travere Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为915.51%、220.19%、134.78%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Intensity Therapeutics, Inc.,振幅分别为24.63%、21.96%、20.64%。Onconetix, Inc.公司简介:Onconetix Inc 是一家处于商业化阶段的生物技术公司,专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1147603757","title":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1147603757","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147603757?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:09","pubTimestamp":1760609347,"startTime":"0","endTime":"0","summary":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2572581647","title":"Onconetix, Inc.盘中异动 快速跳水5.61%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572581647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572581647?lang=zh_cn&edition=full","pubTime":"2025-09-30 23:56","pubTimestamp":1759247769,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日23时56分,Onconetix, Inc.股票出现波动,股价快速跳水5.61%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scisparc Ltd.、Zura Bio Limited涨幅较大,Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2059.74%、316.11%、281.99%,振幅较大的相关个股有Zura Bio Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为50.84%、44.81%、35.39%。Onconetix, Inc.公司简介:Onconetix Inc 是一家处于商业化阶段的生物技术公司,专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1140205978","title":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,终止与Ocuvex Inc.的并购协议并与Veru Inc.达成880万美元债务和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1140205978","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140205978?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:33","pubTimestamp":1758889989,"startTime":"0","endTime":"0","summary":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,同时终止与Ocuvex Inc.的并购协议,并与Veru Inc.达成880万美元债务和解。\n此次融资将为公司提供重要的资金支持,而终止与Ocuvex Inc.的合并协议以及与Veru Inc.达成的债务和解协议,将有助于公司重新调整战略方向,专注于核心业务发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1160349549","title":"Onconetix Inc与Ocuvex决定各自独立发展最符合利益相关者利益","url":"https://stock-news.laohu8.com/highlight/detail?id=1160349549","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160349549?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:17","pubTimestamp":1758889038,"startTime":"0","endTime":"0","summary":"Onconetix Inc与Ocuvex经过评估后认为,双方各自独立发展的路径最符合利益相关者的最佳利益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1137053033","title":"Onconetix Inc.宣布子公司Proteomedix向Immunovia授权制造知识产权,助力后者独立生产胰腺癌检测试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1137053033","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137053033?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:01","pubTimestamp":1758542487,"startTime":"0","endTime":"0","summary":"Onconetix Inc.日前宣布,其子公司Proteomedix已向Immunovia授权相关制造知识产权,此举将使Immunovia能够独立生产其胰腺癌检测产品PancreasureTM所需的关键试剂。\n通过这项授权协议,Immunovia将获得必要的技术支持,提升其在胰腺癌早期检测领域的自主生产能力,进一步巩固其在精准医疗诊断市场的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2518327463","title":"Onconetix, Inc.盘中异动 急速下跌10.39%报0.206美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518327463?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613561,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分,Onconetix, Inc.股票出现异动,股价快速下挫10.39%。截至发稿,该股报0.206美元/股,成交量24.7271万股,换手率1.70%,振幅8.13%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2516634706","title":"Onconetix, Inc.盘中异动 早盘股价大涨8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634706?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012392,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分,Onconetix, Inc.股票出现波动,股价大幅拉升8.04%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Bioxcel Therapeutics, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为47.50%、28.40%、23.97%,振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Bioxcel Therapeutics, Inc.,振幅分别为21.22%、19.25%、10.83%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2514032000","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.57%报0.290美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514032000?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分,Onconetix, Inc.股票出现异动,股价快速下挫5.57%。截至发稿,该股报0.290美元/股,成交量4.7292万股,换手率0.33%,振幅1.30%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4007","BK4139","ONCO"],"gpt_icon":0},{"id":"2512314483","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.60%报0.472美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512314483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512314483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:38","pubTimestamp":1739975921,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时38分,Onconetix, Inc.股票出现波动,股价急速下挫5.60%。截至发稿,该股报0.472美元/股,成交量6.3897万股,换手率0.44%,振幅2.60%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2510863052","title":"Onconetix, Inc.盘中异动 急速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863052?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:39","pubTimestamp":1739198358,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时39分,Onconetix, Inc.股票出现波动,股价急速跳水5.26%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为1867.40%、1005.17%、682.93%,振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Invivyd, Inc.,振幅分别为42.01%、34.46%、29.90%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","ONCO"],"gpt_icon":0},{"id":"2509744221","title":"Onconetix, Inc.盘中异动 早盘快速跳水6.46%报0.612美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744221?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:47","pubTimestamp":1738939626,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时47分,Onconetix, Inc.股票出现波动,股价大幅下跌6.46%。截至发稿,该股报0.612美元/股,成交量5.1838万股,换手率0.36%,振幅5.83%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224706961b3bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224706961b3bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2509094466","title":"Onconetix, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509094466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509094466?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分,Onconetix, Inc.股票出现异动,股价快速上涨5.09%。Onconetix, Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1628.65%、925.01%、444.73%,振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd,振幅分别为72.82%、49.88%、47.29%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001513abc23c81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001513abc23c81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2508114921","title":"Onconetix, Inc.盘中异动 早盘快速跳水5.40%报0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508114921?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分,Onconetix, Inc.股票出现异动,股价大幅跳水5.40%。截至发稿,该股报0.515美元/股,成交量7.118万股,换手率0.49%,振幅0.00%。Onconetix, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。Onconetix, Inc.公司简介:Onconetix Inc 是一家商业阶段的生物技术公司,专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231059616fb27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231059616fb27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":-0.156},{"period":"1month","weight":-0.3081},{"period":"3month","weight":-0.5641},{"period":"6month","weight":-0.6161},{"period":"1year","weight":-0.9771},{"period":"ytd","weight":-0.2372}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司,专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生(BPH)(一种前列腺疾病)的口服治疗药物EntadFi,以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原(PSA)评估不确定的男性的先进专有诊断系统Proclarix。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.03565},{"month":2,"riseRate":0,"avgChangeRate":-0.21533},{"month":3,"riseRate":0.25,"avgChangeRate":-0.182623},{"month":4,"riseRate":0,"avgChangeRate":-0.309723},{"month":5,"riseRate":0.75,"avgChangeRate":0.202403},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145881},{"month":7,"riseRate":0.25,"avgChangeRate":0.061534},{"month":8,"riseRate":0,"avgChangeRate":-0.163365},{"month":9,"riseRate":0.25,"avgChangeRate":-0.19953},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.20858}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}